Market Snapshot:
The biopharmaceutical industry is attractive because of the cost benefits and continuous medical innovation. The highest spending is done by the United States government of the biopharmaceutical industry. Across the globe, there is an increasing number of research and development which enhance drug discovery. The biopharmaceutical industry is helping the way in developing vaccines and treatment for COVID-19. In today's market situation biopharmaceutical manufacturers are working on phase 1 studies for vaccines and treatment. Biomedical innovation is life-threatening to addressing human health challenges. With the development of life sciences, the innovation system depends on robust public and private funding of biomedical R&D. With the increasing government support for biomedical innovation is defended in part on the grounds that is used by a wide range of innovators.
Highlights from Biopharmaceutical Logistics Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
CAGR | 6.2% |
The key Players profiled in the report are FedEx Corporation (United States), Ceva Logistics LLC (Switzerland), Amerisource Bergen Corporation (United States), Panalpina Group (Switzerland), Kuehne + Nagel International AG (Switzerland), XPO Logistics, Inc (United States), United Parcel Service, Inc (United States), Deutsche Post DHL Group (Germany), DB Schenker (Germany) and C.H. Robinson Worldwide (United States). Additionally, other players that are part of this comprehensive study are BioPharma Logistics (Belgium), Cavalier Logistics (United States) and Yourway (United States).
Geographic Breakdown and Segment Analysis
The Global Biopharmaceutical Logistics market presents a comprehensive analysis of the Biopharmaceutical Logistics market by product type (Cold Chain Logistics and Non-Cold Chain Logistics), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Biopharmaceutical Logistics industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest.
For instance, while the holds majority of market share of the Biopharmaceutical Logistics market
Analyst at AMA have segmented the market study of Global Biopharmaceutical Logistics market by Type, Application and Region.
Influencing Trend:
In Biosimilar Market Companies Are Facing Cost Declining Market, And Increasing Competition and Increasing Number of Public and Private Partnership, Because of the Growing Interest Brazilian Health System
Market Growth Drivers:
Development in Biosimilars Market and Growing Demand for Biological Treatment from Chronic Diseases Including Diabetes and Cancer
Challenges:
Variation in Regulation and High Complexity of Manufacturing
Restraints:
Increase in Market Competency
Opportunities:
Increasing Number of Launches by the Leading Industry Players and Biosimilars are Expecting a Huge Role in the Pharmaceutical Market in the Coming Years. The Major Reason Behind its Adoption is Cost-Saving, Biological Treatment Attainability
In 2021, DHL Supply Chain has announced that it has expanded its pharmaceutical logistics capabilities with the construction of an approximately 32,000 square meter building in Florstadt, Germany. The facility is expected to provide additional warehouse space in temperature zones of 2-8°C, -24°C and 15-25°C. and In Jun 2020, Sumitovant Biopharma Ltd. announced an agreement with Sunovion pharmaceuticals. Under this agreement, the company provides services including account management, contract management, and others. Through these initiatives, the company will become more competitive in the coming years.
The market is seeing strong rivalry among market players, this market is having huge growth. The key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. There is a various growth opportunity in this market which is captured by market-leading players through tracking the ongoing process enhancement and huge invest in market growth strategies.
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analyst and Strategic Business Planners, Biopharmaceuticals Logistics Providers, Government Regulatory and Research Organizations and End-Use Industries